Dr Siavash Foroughi
Honorary (Fellow)
Department of Medical Biology (WEHI)
20 Scholarly works
0 Projects
HIGHLIGHTS
2026
Journal article
PvDBP gene amplification is associated with functional immune evasion by Plasmodium vivax in vivo.
DOI: 10.21203/rs.3.rs-9081241/v12025
Journal article
Circulating tumor DNA-guided adjuvant therapy in locally advanced colon cancer: the randomized phase 2/3 DYNAMIC-III trial
DOI: 10.1038/s41591-025-04030-w2025
Journal article
DOP109 A necroptotic-to-apoptotic signaling axis underlies inflammatory bowel disease
DOI: 10.1093/ecco-jcc/jjae190.01482025
Journal article
Baseline and Early On-treatment Circulating Tumour DNA Fraction Are a Key Prognostic Biomarker in Metastatic Castration-resistant Prostate Cancer Treated with [177Lu]Lu-PSMA-617
DOI: 10.1016/j.eururo.2025.08.0152023
Journal article
BRCA-deficient metastatic prostate cancer has an adverse prognosis and distinct genomic phenotype
DOI: 10.1016/j.ebiom.2023.1047382023
Conference Proceedings
Genomic aberrations in circulating tumor DNA (ctDNA) and clinical outcomes from [177Lu] Lu-PSMA-617 in metastatic castration-resistant prostate cancer (mCRPC)
DOI: 10.1158/1538-7445.AM2023-56142022
Conference Proceedings
Prognostic and predictive utility of DNA damage response (DDR) aberrations detected in cell-free DNA (cfDNA) in metastatic castration-resistant prostate cancer (mCRPC).
DOI: 10.1200/JCO.2022.40.6_suppl.153
RECENT SCHOLARLY WORKS
2022
Conference Proceedings
Age-based assessment of cell-free DNA genomic profiles in metastatic castration-resistant prostate cancer (mCRPC).
DOI: 10.1200/JCO.2022.40.6_suppl.1502021
Conference Proceedings
Genomic landscape of older versus younger men with metastatic castration-resistant prostate cancer
2021
Journal article
Independent prognostic impact of plasma NCOA2 alterations in metastatic castration-resistant prostate cancer
DOI: 10.1002/pros.24194